Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LLY | NVO | JNJ | ||
| Company | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 746.12 | 103.18 | 153.62 | ||
| High | 753.00 | 103.22 | 156.06 | ||
| Low | 735.00 | 101.51 | 152.81 | ||
| Last | 749.92 | 102.63 | 155.50 | ||
| Change | -3.49 | -2.64 | +2.39 | ||
| % Change | -0.46% | -2.51% | +1.56% | ||
| Volume | 3,957,663 | 5,827,772 | 9,221,490 | ||
| 20-Day Average Volume | 5,478,739 | 6,691,575 | 7,198,213 | ||
| Previous Close | 753.41 | 105.27 | 153.11 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 807.97 | 107.76 | 156.67 | ||
| 20-Day Raw Stochastic | 18.91% | 21.19% | 38.22% | ||
| 20-Day Relative Strength | 33.66% | 35.11% | 44.37% | ||
| Weighted Alpha | +10.40 | -14.06 | +1.12 | ||
| Today's Opinion | 56% Sell | 100% Sell | 8% Sell | ||
| Previous Opinion | 56% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 40% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.79% since 11/14/24 | -2.63% since 11/14/24 | +2.58% since 11/14/24 | ||
| Low | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 150.90 on 11/15/24 | ||
| High | 777.98 on 11/15/24 | 105.74 on 11/20/24 | 156.06 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -17.39% since 10/21/24 | -12.60% since 10/21/24 | -4.32% since 10/21/24 | ||
| Low | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 150.76 on 11/14/24 | ||
| High | 911.12 on 10/22/24 | 116.65 on 10/22/24 | 166.00 on 10/23/24 | ||
| 3-Month | |||||
| %Chg | -21.37% since 08/21/24 | -24.01% since 08/21/24 | -3.49% since 08/21/24 | ||
| Low | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 150.76 on 11/14/24 | ||
| High | 972.53 on 08/22/24 | 139.74 on 08/30/24 | 168.85 on 09/04/24 | ||
| 6-Month | |||||
| %Chg | -6.80% since 05/21/24 | -24.13% since 05/21/24 | +3.01% since 05/21/24 | ||
| Low | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 143.71 on 05/29/24 | ||
| High | 972.53 on 08/22/24 | 148.15 on 06/25/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 715,224,192 | 472,402,528 | 368,631,168 | ||
| Shares Outstanding, K | 949,316 | 4,487,532 | 2,407,623 | ||
| Annual Sales | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | 11,439,100,000 | 10,511,240,000 | 22,471,000,000 | ||
| Last Quarter Net Income | 970,300,000 | 4,024,170,000 | 2,694,000,000 | ||
| 60-Month Beta | 0.43 | 0.42 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.18 on 10/30/24 | 0.90 on 11/06/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | 10/30/24 | 11/06/24 | 10/15/24 | ||
| Most Recent Dividend | 1.300 on 11/15/24 | 0.362 on 08/16/24 | 1.240 on 08/27/24 | ||
| Next Ex-Dividends Date | 11/15/24 | 08/16/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 71.75 | 33.21 | 14.94 | ||